• 청정기술
• /
• 제26권3호
• /
• pp.196-203
• /
• 2020

본 연구에서는 Cu/hexaaluminate를 공침법으로 제조한 후, 바인더를 첨가하여 펠렛 형태로 성형하였다. 니켈 및 루테늄 조촉매의 첨가가 Cu/hexaaluminate pellet 촉매의 특성과 ADN계 액체 단일 추진제의 분해 반응에 미치는 영향을 고찰하는데 초점을 두었다. Cu/hexaaluminate pellet 촉매는 미세 기공은 거의 없으며 메조 기공이 발달한 촉매이다. Cu/hexaaluminate pellet 촉매에 루테늄을 조촉매로 첨가하면 기공의 부피와 기공의 크기는 큰 폭으로 증가하였다. ADN 기반 액체 단일 추진제의 열분해 반응에서 분해 개시 온도는 170.2 ℃이다. Cu/hexaaluminate pellet 촉매를 사용한 경우, 분해 개시 온도는 93.5 ℃로 크게 감소한 것을 확인하였다. 루테늄 1% 및 3%를 조촉매로 첨가했을 때, ADN 기반 액체 단일 추진제 분해 개시 온도가 각각 91.0 ℃와 83.3 ℃로 낮아졌다. 즉, 루테늄 조촉매가 ADN 기반 액체 단일 추진제의 분해 개시 온도를 낮추는데 효과가 있다는 것을 의미한다. 이는 루테늄 금속이 ADN 기반 액체 단일 추진제 분해 반응에 활성이 뛰어나면서, 동시에 기공 부피와 기공의 크기를 증가시키는데 기여하였기 때문이다. Cu/hexaaluminate pellet 촉매의 내열성에 루테늄이 미치는 영향을 확인하기 위하여 1200 ℃에서의 열처리와 ADN 기반 액체 단일 추진제 분해 실험을 반복적으로 수행한 결과, 루테늄의 첨가 비율이 증가함에 따라 내열성이 증가하는 것을 확인할 수 있었다.

• 분석과학
• /
• 제19권5호
• /
• pp.422-432
• /
• 2006

VOC는 대기오염의 주원인으로서 인식되어왔다. 촉매산화는 저온에서 높은 효율을 나타내기 때문에 VOCs 제거를 위한 가장 중요한 처리기술중 하나이다. 이 연구에서는 ${\gamma}-Al_2O_3$ 담체에 Pt, Pt-Ru 그리고 Pt-Ir을 담시지켜 촉매를 제조하였다. 반응물로서 Xylene, toluene 그리고 MEK를 사용하였다. 단일 또는 두 가지 이상의 촉매들은 함침법에 의해 준비하였고, XRD, XPS, TEM, BET 분석을 통하여 특성화하였다. 그 결과 Pt-Ru, Pt-Ir 촉매는 Pt 촉매에 비해 더 높은 전환율을 나타내었다. ${\gamma}-Al_2O_3$ 담체상에서 Pt-Ir 촉매가 가장 높은 전환율을 보인다. VOCs산화에서, Pt-Ru, Pt-Ir 촉매는 다양한 활성점을 나타내었고 그것은 Pt의 metal 영역를 강화시켰다. 따라서 두 가지 금속으로 이루어진 촉매가 단일 금속으로 이루어진 촉매에 비해 VOCs 전환율이 더 높았다. 이 연구에서 Pt에 소량의 Ru, Ir 첨가는 VOCs의 산화반응을 증진시켰다.

• Archives of Pharmacal Research
• /
• 제27권4호
• /
• pp.407-414
• /
• 2004

The expression of CYP3A4 gene is induced by a variety of structurally unrelated xenobiotics including the antibiotic rifampicin, pregnenolone 16-carbonitrile (PCN), and endogenous hormones, that might mediate through steroid and xenobiotic receptor (SXR) system. The molecular mechanisms underlying regulation of CYP3A4 gene expression have not been understood. In order to gain the insight of the molecular mechanism of CYP3A4 gene expression, study has been undertaken to investigate if the histone deacetylation is involved in the regulation of CYP3A4 gene expression by proximal promoter in human hepatoma HepG2 cells. Also we have investigated to see if SXR is involved in the regulation of CYP3A4 proximal promoter activity in human hepatoma HepG2 cells. HepG2 cells were transfected with a plasmid PCYP3A4-Luc containing ${\~}1kb$ of the CYP3A4 proximal promoter region (-863 to +64 bp) in front of a reporter gene, luciferase, in the presence or absence of pSAP-SXR. In HepG2 cells, CYP3A4 inducers, such as rifampicin, PCN and RU486 showed minimal stimulation of CYP3A4 proximal promoter activity in the absence of SXR and histone deacetylase (HDAC) inhibitors. 4-Dimethylamino-H-[4-(2-hydroxycarbamoylvinyl)benzyl]benzamide (IN2001), a new class HDAC inhibitor significantly increased CYP3A4 proximal promoter activity over untreated control cells and rifampicin concomitant treatment with IN2001 increased further CYP3A4 proximal promoter activity that was stimulated by IN2001 The results of this study demon-strated that both HDAC inhibitors and SXR are essential to increase of CYP3A4 proximal promoter activity by CYP3A4 inducers such as PCN, rifampicin, and RU486. Especially SXR seems to be important for the dose dependent response of CYP3A4 inducing chemicals to stimulate CYP3A4 proximal promoter activity. Also this data suggested that HDAC inhibitors seemed to facilitate the CYP3A4 proximal promoter to be activated by chemicals.

• 한국연소학회:학술대회논문집
• /
• 한국연소학회 2014년도 제49회 KOSCO SYMPOSIUM 초록집
• /
• pp.355-356
• /
• 2014

Catalytic steam reforming of tar produced from biomass gasification was conducted using several Ni-based catalysts. K and Mn were used as a promoter over $Ni/Ru/Al_2O_3$ catalyst. The pellet and monolith type catalysts were prepared and applied to lab and bench-scale biomass gasification system. The $Ni/Ru-K/Al_2O_3$ catalyst shown higher performance than $Ni/Ru-Mn/Al_2O_3$ catalyst at low temperature range.

• Archives of Pharmacal Research
• /
• 제27권4호
• /
• pp.415-421
• /
• 2004

Cytochrome P450 3A4 (CYP3A4) is the most abundant CYPs in human liver, comprising approximately $30\%$ of the total liver CYPs contents and is involved in the metabolism of more than $60\%$ of currently used therapeutic drugs. However, the molecular mechanisms underly-ing regulation of CYP3A4 gene expression have not been understood. Thus, this study has been carried out to gain the insight of the molecular mechanism of CYP3A4 gene expression, investigating if the histone deacetylation is involved in the regulation of CYP3A4 gene expression by proximal promoter. Also SXR was investigated to see if they were involved in the regulation of CYP3A4 proximal promoter activity. Hepa-1 cells were transfected with a plasmid containing ${\~}1kb$ of the human CYP3A4 proximal promoter region (863 to +64 bp) cloned in front of a reporter gene, luciferase, in the presence or absence of SXR. Transfected cells were treated with CYP3A4 inducers such as rifampicin, PCN and RU 486, in order to examine the regulation of CYP3A4 gene expression in the presence or absence of trichostatin A (TSA). In Hepa-1 cells, CYP3A4 inducers increased modestly the luciferase activity when TSA was co-treated, but this increment was not enhanced by SXR cotransfection. Taken together, these results indicated that the inhibition of histone deacetylation was required to SXR-mediated increase in CYP3A4 proximal promoter region when rifampicin, or PCN was treated. Further a trans-activation by SXR may demand other species-specific transcription factors.

• 한국환경성돌연변이발암원학회지
• /
• 제24권4호
• /
• pp.171-179
• /
• 2004

Cytochrome P4503A4(CYP3A4) is the most abundnat CYPs in human liver, comparising approximately 30% of the total liver CYPs contents ans is involbed in the metabolism of more than 60% of currently used therapeutic drugs. The expression of CYP3A4 is induced by a variety of structurally unrelated xonobiotics including the antibiotic rifampicin and endogenous hormones, and might be mediated through steroid and xenobiotic receptor(SXR) system. The molecular mechanisms underlying regulation of CYP3A4 gene expression hae not been understood. In order to gain the insight of the molecular mechanism of CYP3A4 gene expression, study has been undertaken to investigate if the histone deacelylation is involved in the regulation of CYP3A4 gene expression by proximal promoter or not. Also SXR was investigated to see if they were involved in the regulation of CYP3A4 proximal promoter activity. HepG2 or Hena-I cells were transfected with a plasmid containing~1kb of the CYP3A4 proximal promoter region (-863 to +64bp) cloned in front of a reporter gene, luciferase, in the presence or absence of SXR or hER. Transfected cells were treated with CYP3A4 inducers such as rifampicin, PCN and RU 486, or with estradiol, in order to exmine to regulation of CYP3A4 gene expression in the presence or absence of trichostatin A (TSA). In HepG2 cells, CYP3A4 inducers and estradiol increased significantly the luciferase activity by CYP3A4 proximal promoter, only when TSA was co-treated after SXR cotransfection. In the case of Hepa-I cells CYP3A4 inducers and estradiol incressed modestly the luciferase activity when TSA was co-treated, but this increment was not enhanced by SXR cotransfection in contrast to HepG2 cells. Taken together, these results indicated that the inhibition of histone deacetylation was required to SXR-mediated increase in CYP3A4 proximal promoter region when rifampicin, or PCN was treated. Futher a trans-activation by SXR may demand other species-specific transcription factors.

• 공업화학
• /
• 제35권2호
• /
• pp.134-139
• /
• 2024

메탄의 수증기 개질 반응에서 Ni 기반 촉매에 귀금속 Ru 및 Pd을 조촉매로 첨가하여 촉매의 활성 및 수소 생산에 미치는 영향을 분석하였다. 합성된 촉매는 허니컴 구조의 금속 모노리스 구조체 표면에 코팅하여 수증기 메탄 개질 반응을 수행하였다. 촉매의 특성은 XRD, TPR 및 SEM으로 분석하였으며 개질 반응 후 가스를 포집하여 GC로 조성을 분석한 후 메탄의 전환율, 수소 수율 및 CO 선택도를 측정하였다. 0.5 wt%의 Ru 첨가는 Ni의 환원 특성을 개선하였고, 99.91%의 메탄 전환율로 향상된 촉매 활성을 나타내었다. 또한, 다양한 공정 조건에 따른 반응 특성을 분석하였으며, 800 ℃의 반응 온도, 10000 h^-1 이하의 공간속도(GHSV), 3 이상의 H₂O와 CH₄의 비(S/C)에서 90% 이상의 메탄 전환율과 3.3 이상의 수소 수율을 얻을 수 있었다.

• BMB Reports
• /
• 제32권6호
• /
• pp.521-528
• /
• 1999

The folding of recombinant hepatitis B virus X-protein (rHBx) solubilized from Escherichia coli inclusion bodies was investigated. By sequential dialysis of urea, rHBx was folded into its native structure, which was demonstrated by the efficacy of its transcriptional activation of the adenovirus major late promoter (MLP), fluorescence spectroscopy, and circular dichroism (CD) analysis. The decrease in CD values at 220 nm and a corresponding blue shift of the intrinsic fluorescence emission confirmed the ability of rHBx to refold in lower concentrations of urea, yielding the active protein. Equilibrium and kinetic studies of the refolding of rHBx were carried out by tryptophan fluorescence measurements. From the biphasic nature of the fluorescence curves, the existence of stable intermediate states in the renaturation process was inferred. Reverse phase-high performance liquid chromatography (RP-HPLC) analysis further demonstrated the existence of these intermediates and their apparent compactness.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권23호
• /
• pp.10325-10328
• /
• 2015

RASSF1A, regarded as a candidate tumor suppressor, is frequently silenced and inactivated by methylation of its promoter region in many human tumors. However, the association between RASSF1A promoter methylation and lung cancer risk remains unclear. To provide a more reliable estimate we conducted a meta-analysis of cohort studies to evaluate the potential role of RASSF1A promoter methylation in lung carcinogenesis. Relevant studies were identified by searches of PubMed, Web of Science, ProQest and Medline databases using the following key words: 'lung cancer or lung neoplasm or lung carcinoma', 'RASSF1A methylation' or 'RASSF1A hypermethylation'. According to the selection standard, 15 articles were identified and analysised by STATA 12.0 software. Combined odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of the association between RASSF1A promoter methylation and lung cancer risk. A chi-square-based Q test and sensitivity analyses were performed to test between-study heterogeneity and the contributions of single studies to the final results, respectively. Funnel plots were carried out to evaluate publication bias. Overall, a significant relationship between RASSF1A promoter methylation and lung cancer risk (OR, 16.12; 95%CI, 11.40-22.81; p<0.001) with no between-study heterogeneity. In subgroup analyses, increased risk of RASSF1A methylation in cases than controls was found for the NSCLC group (OR, 13.66, 95%CI, 9.529-19.57) and in the SCLC group (OR, 314.85, 95%CI, 48.93-2026.2).

• 멤브레인
• /
• 제28권5호
• /
• pp.297-306
• /
• 2018

본 총설은 분리막기술이 적용된 수소생산에 대한 개론으로, 특히, 암모니아를 수소운반체로 이용하는 수소생산에 대한 연구결과를 중점적으로 서술하였다. 암모니아를 수소운반체로 적용한 수소생산은 추가적인 탄소생성이 없다는 점 외에 여러 측면에 있어 이점이 있다. 많은 연구들이 고순도 수소 분리 및 생산을 위한 분리막 개발을 위해 진행되고 있으며, 이들 중 팔라듐을 기본으로 한 분리막(예를 들어, 다공성 세라믹 또는 다공성 금속 지지체와 팔라듐 합금의 얇은 선택층으로 이루어진 분리막)에 대한 연구가 활발하다. 반면에, 효율적인 암모니아 분해를 위해서는 주로 루테늄 촉매가 적용되고 있으며, 루테늄과 지지체 및 촉진제로 이루어진 루테늄에 기반을 둔 촉매에 대한 연구발표가 다수 존재한다. 수소생산을 위한 분리막 반응기 형태로는 충전층, 유동층, 그리고 마이크로반응기 등이 있으며, 이들의 최적화 및 원활한 물질전달 연구는 현재진행형이다. 또한, 높은 암모니아 분해율, 고순도 수소생산 및 높은 수소생산율을 얻기 위해 분리막과 촉매의 다양한 조합에 대한 연구 및 분리막과 촉매의 역할을 동시에 구현할 수 있는 분리막에 대한 연구가 발표되고 있다.